CTLA-4-directed Blocking Antibody drugs

2 medications in the FDA established pharmacologic class “CTLA-4-directed Blocking Antibody”.

DrugTypeNDC products
Imjudo
tremelimumab		Rx2
Yervoy
ipilimumab		Rx2